{
    "clinical_study": {
        "@rank": "161653", 
        "brief_summary": {
            "textblock": "To compare the safety of atovaquone (566C80) with intravenous (IV) pentamidine for the\n      treatment of mild to moderate Pneumocystis carinii pneumonia (PCP) in AIDS patients who are\n      intolerant of therapy with trimethoprim /  sulfamethoxazole (TMP / SMX) by comparing the\n      incidence of premature discontinuation of therapy due to toxicity. To compare the efficacy\n      of 566C80 with intravenous (IV) pentamidine for the treatment of mild to moderate PCP in the\n      same population."
        }, 
        "brief_title": "A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole", 
        "condition": [
            "Pneumonia, Pneumocystis Carinii", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Pneumonia", 
                "Pneumonia, Pneumocystis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have the following:\n\n          -  History of, or are currently experiencing, intolerance to TMP / SMX, or to another\n             sulfonamide, which required discontinuation of therapy.\n\n          -  Pneumocystis carinii pneumonia (PCP).\n\n          -  Willing and able to give informed consent.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following conditions or symptoms are excluded.\n\n          -  Malabsorption disorder or vomiting that would, in the judgement of the investigator,\n             potentially limit the retention and absorption of an oral therapy.\n\n          -  Concurrent bacterial, fungal, or viral pneumonitis, pulmonary Kaposi's sarcoma, or\n             other concurrent illness, or chronic pulmonary disease that, in the investigator's\n             opinion, would make interpretation of drug efficacy difficult.\n\n          -  Present occurrences of abnormal prolongation of QT interval on standard, 12 lead EKG.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Drugs with potential anti-pneumocystis effect (eg:\n\n          -  sulfonamides, dapsone, trimethoprim, other dihydrofolate reductase (DHFR) inhibitors,\n             primaquine, clindamycin, sulfonylureas).\n\n          -  Ganciclovir.\n\n          -  Zidovudine.\n\n          -  Investigational agents including anti-retroviral agents (ddI, ddC, etc.). Patients\n             receiving these drugs prior to entry must discontinue their use during the therapy\n             phase (21 days) of the trial.\n\n          -  Corticosteroids (except replacement therapy) during the 21 day treatment period\n             (Strata A and C Patients).\n\n          -  Class 1A antiarrhythmics (ie:\n\n          -  quinidine, procainamide, disopyramide).\n\n        Patients with the following are excluded:\n\n          -  Judged by the investigator to be in impending respiratory failure.\n\n          -  Known intolerance to parenteral pentamidine isethionate, or therapeutic failure with\n             same for treatment of current episode of PCP.\n\n          -  Significant psychosis or emotional disorder that, in the investigator's opinion,\n             would preclude the patient from adhering to the protocol.\n\n          -  Inability or unwillingness to take medication orally or with food.\n\n          -  Prior documented glucose-6-phosphate dehydrogenase (G6PD) deficiency.\n\n          -  History, or present occurrences, of abnormal prolongation of QT interval on standard,\n             12 lead EKG.\n\n          -  Termination from FDA 053A due to toxicity.\n\n          -  For patients entering under historic intolerance criteria (Groups A and B), prior\n             therapy for this episode of PCP is an exclusion.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Treatment within 4 weeks of entry for a prior episode of PCP.\n\n          -  For patients entering under historic intolerance criteria (Groups A and B), prior\n             therapy for this episode of PCP is an exclusion.\n\n        Required:\n\n          -  Adjuvant prednisone for patient enrolled in Strata B or D."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001996", 
            "org_study_id": "053B", 
            "secondary_id": "05"
        }, 
        "intervention": [
            {
                "intervention_name": "Atovaquone", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Pentamidine isethionate", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Pentamidine", 
                "Trimethoprim", 
                "Trimethoprim-Sulfamethoxazole Combination", 
                "Atovaquone", 
                "Sulfamethoxazole"
            ]
        }, 
        "keyword": [
            "Trimethoprim-Sulfamethoxazole Combination", 
            "Pneumonia, Pneumocystis carinii", 
            "Pentamidine", 
            "Acquired Immunodeficiency Syndrome", 
            "atovaquone"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Berkeley", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94704"
                    }, 
                    "name": "East Bay AIDS Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Harbor City", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90710"
                    }, 
                    "name": "Kaiser Foundation Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90048"
                    }, 
                    "name": "Cedars Sinai Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095"
                    }, 
                    "name": "UCLA CARE Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orange", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92668"
                    }, 
                    "name": "UCI Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Redwood City", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94063"
                    }, 
                    "name": "AIDS Community Research Consortium"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94114"
                    }, 
                    "name": "Davies Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Ramone", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94583"
                    }, 
                    "name": "Dr Patrick Joseph"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30345"
                    }, 
                    "name": "Infectious Disease Research Consortium of Georgia"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02118"
                    }, 
                    "name": "Boston City Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114"
                    }, 
                    "name": "Massachusetts Gen Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10011"
                    }, 
                    "name": "Saint Vincent's Hosp and Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10003"
                    }, 
                    "name": "Beth Israel Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10037"
                    }, 
                    "name": "Harlem AIDS Treatment Group / Harlem Hosp Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "452670405"
                    }, 
                    "name": "Univ of Cincinnati"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97210"
                    }, 
                    "name": "Portland Veterans Adm Med Ctr / Rsch & Education Grp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19107"
                    }, 
                    "name": "Buckley Braffman Stern Med Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Memphis", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "38103"
                    }, 
                    "name": "Regional Med Ctr at Memphis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77004"
                    }, 
                    "name": "Gathe, Joseph, M.D."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Baylor College of Medicine"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "reference": {
            "citation": "Dohn M, Weinberg W, Rosenstock J, Follansbee S, Torres R, Caldwell P. Atovaquone vs. pentamidine for pneumocystis carinii pneumonia in patients with AIDS. Int Conf AIDS. 1993 Jun 6-11;9(1):372 (abstract no PO-B10-1421)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001996"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Glaxo Wellcome", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 1992"
    }, 
    "geocoordinates": {
        "AIDS Community Research Consortium": "37.485 -122.236", 
        "Baylor College of Medicine": "29.76 -95.369", 
        "Beth Israel Med Ctr": "40.714 -74.006", 
        "Boston City Hosp": "42.358 -71.06", 
        "Buckley Braffman Stern Med Associates": "39.952 -75.164", 
        "Cedars Sinai Med Ctr": "34.052 -118.244", 
        "Davies Med Ctr": "37.775 -122.419", 
        "Dr Patrick Joseph": "37.78 -121.978", 
        "East Bay AIDS Ctr": "37.872 -122.273", 
        "Gathe, Joseph, M.D.": "29.76 -95.369", 
        "Harlem AIDS Treatment Group / Harlem Hosp Ctr": "40.714 -74.006", 
        "Infectious Disease Research Consortium of Georgia": "33.749 -84.388", 
        "Kaiser Foundation Hosp": "33.791 -118.297", 
        "Massachusetts Gen Hosp": "42.358 -71.06", 
        "Portland Veterans Adm Med Ctr / Rsch & Education Grp": "45.523 -122.676", 
        "Regional Med Ctr at Memphis": "35.15 -90.049", 
        "Saint Vincent's Hosp and Med Ctr": "40.714 -74.006", 
        "UCI Med Ctr": "33.788 -117.853", 
        "UCLA CARE Ctr": "34.052 -118.244", 
        "Univ of Cincinnati": "39.103 -84.512"
    }
}